Fasudil fOr redUcing elopemeNt and Spatial Disorientation
Clinical trial NCT04793659 · COMPLETED
Trial details
- NCT number
- NCT04793659
- Sponsor
- Woolsey Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2021-12-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.